- Home
- SWVL vs MDCX Comparison
SWVL vs MDCX Comparison
Compare SWVL & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWVL
- MDCX
- Stock Information
- Founded
- SWVL 2017
- MDCX 2008
- Country
- SWVL United Arab Emirates
- MDCX Canada
- Employees
- SWVL N/A
- MDCX N/A
- Industry
- SWVL Business Services
- MDCX
- Sector
- SWVL Consumer Discretionary
- MDCX
- Exchange
- SWVL Nasdaq
- MDCX Nasdaq
- Market Cap
- SWVL 44.5M
- MDCX 44.0M
- IPO Year
- SWVL N/A
- MDCX N/A
- Fundamental
- Price
- SWVL $4.79
- MDCX $3.01
- Analyst Decision
- SWVL
- MDCX Strong Buy
- Analyst Count
- SWVL 0
- MDCX 2
- Target Price
- SWVL N/A
- MDCX $23.50
- AVG Volume (30 Days)
- SWVL 22.8K
- MDCX 503.3K
- Earning Date
- SWVL 07-22-2025
- MDCX 08-22-2025
- Dividend Yield
- SWVL N/A
- MDCX N/A
- EPS Growth
- SWVL N/A
- MDCX N/A
- EPS
- SWVL N/A
- MDCX N/A
- Revenue
- SWVL $17,207,362.00
- MDCX N/A
- Revenue This Year
- SWVL N/A
- MDCX N/A
- Revenue Next Year
- SWVL N/A
- MDCX N/A
- P/E Ratio
- SWVL N/A
- MDCX N/A
- Revenue Growth
- SWVL N/A
- MDCX N/A
- 52 Week Low
- SWVL $2.40
- MDCX $1.80
- 52 Week High
- SWVL $8.05
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- SWVL 64.82
- MDCX N/A
- Support Level
- SWVL $4.08
- MDCX N/A
- Resistance Level
- SWVL $4.89
- MDCX N/A
- Average True Range (ATR)
- SWVL 0.47
- MDCX 0.00
- MACD
- SWVL 0.07
- MDCX 0.00
- Stochastic Oscillator
- SWVL 91.60
- MDCX 0.00
About SWVL Swvl Holdings Corp
Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. It provides mobility solutions for enterprises and government and individual commuters across-multiple markets with clients such as Amazon, Bosch, E&, P&G and Siemens. The Company operates in Egypt, Saudi Arabia and the UAE.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.